Nathalie Compagnone
Directeur Général chez Innovative Concepts in Drug Development SAS
Postes actifs de Nathalie Compagnone
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Innovative Concepts in Drug Development SAS
 Innovative Concepts in Drug Development SAS BiotechnologyHealth Technology Innovative Concepts in Drug Development SAS develops and provides innovative proprietary screening platforms to the pharmaceutical development sector. The company was founded by Natahlie Compagnone in 2007 and is headquartered in Gemenos, France. | Directeur Général | 01/01/2007 | - |
| Directeur Technique/Scientifique/R&D | 01/01/2007 | - | |
| Fondateur | 01/01/2007 | - |
Historique de carrière de Nathalie Compagnone
Anciens postes connus de Nathalie Compagnone
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Trophos SA
 Trophos SA Pharmaceuticals: MajorHealth Technology Trophos SA engages in manufacturing and development of pharmaceutical products. It offers medicines to patients with conditions such as amyotrophic lateral sclerosis, spinal muscular atrophy and cardiac ischemia reperfusion injury. The company was founded by Antoine Beret and Michel Delaage in 1991 and is headquartered in Marseille, France. | Corporate Officer/Principal | 01/01/2004 | - |
| The University of California, San Francisco | Corporate Officer/Principal | 01/01/1999 | - |
Formation de Nathalie Compagnone
| Université de Franche-Comté | Undergraduate Degree |
| Rutgers State University of New Jersey | Masters Business Admin |
Statistiques
Internationale
| France | 4 |
| Etats-Unis | 3 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 1 |
| Masters Business Admin | 1 |
Sectorielle
| Consumer Services | 4 |
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Trophos SA
Trophos SA Pharmaceuticals: MajorHealth Technology Trophos SA engages in manufacturing and development of pharmaceutical products. It offers medicines to patients with conditions such as amyotrophic lateral sclerosis, spinal muscular atrophy and cardiac ischemia reperfusion injury. The company was founded by Antoine Beret and Michel Delaage in 1991 and is headquartered in Marseille, France. | Health Technology |
Innovative Concepts in Drug Development SAS
Innovative Concepts in Drug Development SAS BiotechnologyHealth Technology Innovative Concepts in Drug Development SAS develops and provides innovative proprietary screening platforms to the pharmaceutical development sector. The company was founded by Natahlie Compagnone in 2007 and is headquartered in Gemenos, France. | Health Technology |
- Bourse
- Insiders
- Nathalie Compagnone
- Expérience
